SANEESE STEPHEN: Open Payments
NPI 1477537025 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 34 payments from 8 companies in 2025. Trend: 2023 $1,972 · 2024 $600 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 26 | $329 |
| Astellas Pharma US Inc | 2 | $136 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Astellas Pharma Global Development | 1 | $104 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| PFIZER INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: CABOMETYX, Xtandi, Padcev, Enhertu, LYNPARZA, KEYTRUDA, Nubeqa.
Industry payments across NY — which companies pay providers there.
